Fascinatingly, in lung cancer, IL-1β expression has been related to lung cancer development, and its higher levels in serum or tumor tissue have been correlated with a poorer prognosis for lung cancer patients (Zhang and Veeramachaneni 2022). The gene discussed is IL1B; the disease is lung cancer.